CRISPR Therapeutics Q1 EPS $(1.43) Misses $(1.42) Estimate, Sales $504.00K Miss $28.11M Estimate
CRISPR Therapeutics Q1 EPS $(1.43) Misses $(1.42) Estimate, Sales $504.00K Miss $28.11M Estimate
CRISPR Therapeutics第一季度每股收益美元（1.43美元）未达到预期（1.42美元），销售额为504.00万美元，低于2,811万美元的预期
CRISPR Therapeutics (NASDAQ:CRSP) reported quarterly losses of $(1.43) per share which missed the analyst consensus estimate of $(1.42) by 0.7 percent. This is a 113.43 percent decrease over losses of $(0.67) per share from the same period last year. The company reported quarterly sales of $504.00 thousand which missed the analyst consensus estimate of $28.11 million by 98.21 percent. This is a 99.50 percent decrease over sales of $100.00 million the same period last year.
CRISPR Therapeutics（纳斯达克股票代码：CRSP）公布的季度亏损为每股1.43美元，比分析师普遍预期的1.42美元（1.42美元）低0.7％。这比去年同期每股亏损0.67美元（0.67美元）下降了113.43％。该公司公布的季度销售额为50.4万美元，比分析师共识估计的2811万美元低98.21％。这比去年同期的1亿美元销售额下降了99.50％。